Appleton Partners’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Appleton Partners’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-66,206	Closed	-$69K	–	287
2019 Q1	$69K	Buy	+66,206	New	+$53.9K	0.01%	261

Appleton Partners's OMED Position: Q2 2019 in Review

Appleton Partners sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 66,206 shares — an estimated $69K sold.

Appleton Partners first reported a position in OMED in Q1 2019 and held it in 1 quarter. The position peaked at $69K in Q1 2019. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Appleton Partners reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Appleton Partners sold 66,206 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $69K.
Appleton Partners first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
Appleton Partners's OncoMed Pharmaceuticals, Inc. position peaked at $69K in Q1 2019.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Appleton Partners's 13F filing for Q2 2019, filed 25 Jul 2019.